Madrigal Pharmaceuticals Inc
NASDAQ:MDGL

Watchlist Manager
Madrigal Pharmaceuticals Inc Logo
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Watchlist
Price: 338.54 USD -1.14% Market Closed
Market Cap: 7.5B USD

P/E
Price to Earnings

-15.8
Current
-11.4
Median
21.6
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-15.8
=
Market Cap
7.4B USD
/
Net Income
-465.9m USD
Earnings Growth PEG
US
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Average P/E: 82.8
Negative Multiple: -15.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -172 423.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
88.4
88%
1
US
Amgen Inc
NASDAQ:AMGN
41.6
44%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
278
185%
1.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -246.5 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -495.5 N/A N/A
AU
CSL Ltd
ASX:CSL
28.1
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
11%
1.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.4 N/A N/A
NL
argenx SE
XBRU:ARGX
44.4
19%
2.3

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-24.5
2-Years Forward
P/E
104.6
3-Years Forward
P/E
10.8